Tessera issues ~3.5M shares for MEA stake and DFSL warrant exercise; ATM raises over $6M

BiomX Inc.

Issued 195,000 restricted shares to Mayers Ventures LLC for an equity interest in M.E.A. Testing Systems Ltd. plus an option on Motomova Inc.'s remaining MEA stake.
Issued 3,278,039 restricted shares to Mandragola Ltd. in three cashless exercises of the DFSL Warrant from the April 13, 2026 buy of 60% of Dr. Frucht Systems Ltd.
Shares outstanding 13,983,094 as of Oct 12, 2026, after these issuances and ATM sales; warrant has a $0.10 floor and 9.99% beneficial-ownership blocker.
At-the-market program raised more than $6 million net at an average net price of about $1.11, as adjusted for the one-for-ten reverse split effective Sept 9, 2026.
Management said it may temporarily halt ATM sales depending on market conditions; CEO Michael Oster signed the report Oct 13, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.